Skip to main content

Find Clinical Trials

Home
Conditions
Urticaria

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

93 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Urticaria trial results

Completed

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

NCT04557319

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: State budgetary institution of healthcare of the city of Moscow "Сity polyclinic No. 2 of the Department of healthcare of the city of Moscow" Moscow, Russia

View Trial Details

Completed

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

NCT03137069

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
Locations: Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States

Allergy & Asthma Immunology Associates Scottsdale, Arizona, United States

Kern Allergy Med Clinic, Inc. Bakersfield, California, United States

Southern California Research Center Mission Viejo, California, United States

View all 27 locations

View Trial Details

Completed

Atopic Diseases & Human Papilloma Virus

NCT04397081

Conditions: Asthma, Atopic Asthma, Atopic Disorders, +18 more
Locations: Adana City Education and Research Hospital Adana, Merkez, Turkey (Türkiye)

View Trial Details

Completed

Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.

NCT03296358

Conditions: Allergy, Chronic Disease, Chronic Urticaria, +11 more
Locations: Chulalongkorn Hospital Pathum Wan, Bangkok, Thailand

View Trial Details

Completed

Evaluating for Contact Allergies in Patients With Chronic Urticaria

NCT00868036

Conditions: Allergy, Contact Sensitization, Dermatitis, +12 more
Locations: Tufts Medical Center, Department of Dermatology Boston, Massachusetts, United States

View Trial Details

Completed

Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264

NCT02424799

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
Locations: GSK Investigational Site Berlin, Germany

GSK Investigational Site Berlin, Germany

GSK Investigational Site Norwich, Norfolk, United Kingdom

GSK Investigational Site Norwich, Norfolk, United Kingdom

View Trial Details

Completed

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients

NCT02161562

Conditions: Angioedema, Cardiovascular Diseases, Chronic Disease, +16 more
Locations: Novartis Investigative Site Pilar, Buenos Aires, Argentina

Novartis Investigative Site Santa Fe, Rosario, Argentina

Novartis Investigative Site Rosario, Santa Fe Province, Argentina

Novartis Investigative Site Buenos Aires, Argentina

View all 35 locations

View Trial Details

Completed

Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria

NCT02824393

Conditions: Autoimmune Diseases, Chronic Disease, Chronic Urticaria, +10 more
Locations: Celal Bayar University, Medical School Manisa, Turkey (Türkiye)

View Trial Details

Completed

A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria

NCT02392624

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
Locations: Allergy and Asthma Relief Experts Granada Hills, California, United States

Allergy & Asthma Care Center of Southern California Long Beach, California, United States

Dermatology Research Associate Los Angeles, California, United States

Southern California Research Center Mission Viejo, California, United States

View all 40 locations

View Trial Details

Completed

Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus

NCT03324919

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: University Hospital Regensburg Regensburg, Bavaria, Germany

View Trial Details